| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |